Monogram provided an update regarding its 510(k) premarket filing submission to the FDA for the company’s mBos TKA System. The company has completed all supplemental testing and submitted its formal response to the FDA regarding the additional information request received on September 30, 2024. The company does not currently anticipate further requests for information from the agency.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MGRM: